Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
CRISPR Therapeutics AG
CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.
IPO Date: October 19, 2016
Sector: Healthcare
Industry: Biotech
Market Cap: $4.55B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.62 | 2.80%
Avg Daily Range (30 D): $1.45 | 2.79%
Avg Daily Range (90 D): $1.17 | 2.80%
Institutional Daily Volume
Avg Daily Volume: 1.14M
Avg Daily Volume (30 D): 3.29M
Avg Daily Volume (90 D): 2.4M
Trade Size
Avg Trade Size (Sh.): 64
Avg Trade Size (Sh.) (30 D): 63
Avg Trade Size (Sh.) (90 D): 63
Institutional Trades
Total Inst.Trades: 5,519
Avg Inst. Trade: $2.81M
Avg Inst. Trade (30 D): $4.96M
Avg Inst. Trade (90 D): $3.66M
Avg Inst. Trade Volume: .04M
Avg Inst. Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $5.16M
Avg Closing Trade (30 D): $20.06M
Avg Closing Trade (90 D): $10.14M
Avg Closing Volume: 80.03K
   
News
Jul 21, 2025 @ 4:07 AM
3 Monster Stocks in the Making to Buy Right Now
Source: Multiple Motley Fool Contributors
Jul 9, 2025 @ 12:30 PM
Breaking Through: Systemic Genetic Medicines for H...
Source: Prnewswire
Jun 26, 2025 @ 11:00 AM
CRISPR Therapeutics Reports Positive Additional Ph...
Source: Crispr Therapeutics
Jun 24, 2025 @ 8:17 AM
The Best Stocks to Invest $1,000 in Right Now
Source: James Brumley
Jun 17, 2025 @ 2:07 PM
Editas Medicine Is Great. Here's Why You Shouldn't...
Source: Dan Victor
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-1.58 $-.42 $-4.34
Diluted EPS $-1.58 $-.42 $-4.34
Revenue $ .87M $ 35.69M $ 37.31M
Gross Profit $ $ $
Net Income / Loss $ -136M $ -37.31M $ -366.25M
Operating Income / Loss $ -148.42M $ -64.59M $ -466.57M
Cost of Revenue $ $ $
Net Cash Flow $ -63.11M $ 72.67M $ -91.27M
PE Ratio